Literature DB >> 16832795

A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.

Alan C Geller1, Karen M Emmons, Daniel R Brooks, Catherine Powers, Zi Zhang, Howard K Koh, Timothy Heeren, Arthur J Sober, Frederick Li, Barbara A Gilchrest.   

Abstract

BACKGROUND: Identifying high-risk individuals for melanoma education and risk reduction may be a viable strategy to curb the incidence of melanoma, which has risen precipitously in the past 50 years. The first-degree relatives of melanoma patients represent a risk group who may experience a 'teachable moment' for enhanced education and risk reduction.
METHODS: We report a randomized trial testing an intervention that provided personalized telephone counseling and individually tailored materials to siblings of recently-diagnosed melanoma patients. The purpose of this study was to test whether an intervention could lead to improvements in siblings' skin cancer risk reduction practices. Intervention condition participants received the following: (1) an initial motivational and goal-setting telephone intervention session delivered by the health educator; (2) three sets of computer-generated materials specifically tailored to individual responses from the baseline survey; (3) three telephone counseling sessions with the health educator, timed to follow receipt of the mailed materials; and (4) linkages to free screening programs. Families in the usual care arm received the suggestion from the physician that patients diagnosed with melanoma notify the family members about their diagnosis and encourage the family members to be screened.
RESULTS: 494 siblings were recruited to the study and 403 siblings remained in the study through at least 6 months. At 12 months, intervention siblings were more likely to examine all moles, including those on the back (OR, 1.76; 95% CI, 1.06-2.91). Compared with baseline, the number of participants in both groups that had received a skin cancer examination more than doubled, with no differences between groups. At 12 months, two-thirds of siblings in both groups reported routine use of sunscreen, but there were no differences in change over baseline between the two groups.
CONCLUSIONS: This study is the one of the first, to our knowledge, to address skin cancer risk-reduction strategies in a sample of individuals who have a recent family diagnosis of melanoma. Diagnosis of melanoma in a family member provides an important opportunity to intervene with others in that family. The components of the intervention may provide a useful foundation for future efforts to target the more than half million siblings at risk for melanoma, a lethal but preventable disease.

Entities:  

Mesh:

Year:  2006        PMID: 16832795     DOI: 10.1002/cncr.22050

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  Factors associated with inconsistent sun protection in first-degree relatives of melanoma survivors.

Authors:  Elyse Shuk; Jack E Burkhalter; Carlos F Baguer; Susan M Holland; Alisa Pinkhasik; Mary Sue Brady; Daniel G Coit; Charlotte E Ariyan; Jennifer L Hay
Journal:  Qual Health Res       Date:  2012-07

2.  Brazilian consensus on photoprotection.

Authors:  Sérgio Schalka; Denise Steiner; Flávia Naranjo Ravelli; Tatiana Steiner; Aripuanã Cobério Terena; Carolina Reato Marçon; Eloisa Leis Ayres; Flávia Alvim Sant'anna Addor; Helio Amante Miot; Humberto Ponzio; Ida Duarte; Jane Neffá; José Antônio Jabur da Cunha; Juliana Catucci Boza; Luciana de Paula Samorano; Marcelo de Paula Corrêa; Marcus Maia; Nilton Nasser; Olga Maria Rodrigues Ribeiro Leite; Otávio Sergio Lopes; Pedro Dantas Oliveira; Renata Leal Bregunci Meyer; Tânia Cestari; Vitor Manoel Silva dos Reis; Vitória Regina Pedreira de Almeida Rego
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

Review 3.  Barriers to risk-understanding and risk-reduction behaviors among individuals with a family history of melanoma.

Authors:  Laura Fitzpatrick; Jennifer L Hay
Journal:  Melanoma Manag       Date:  2014-12-04

4.  Skin Cancer Surveillance Behaviors Among Childhood Cancer Survivors.

Authors:  Jerod L Stapleton; Kristina L Tatum; Katie A Devine; Sue Stephens; Margaret Masterson; Amna Baig; Shawna V Hudson; Elliot J Coups
Journal:  Pediatr Blood Cancer       Date:  2015-10-29       Impact factor: 3.167

5.  Piloting the Use of Smartphones, Reminders, and Accountability Partners to Promote Skin Self-Examinations in Patients with Total Body Photography: A Randomized Controlled Trial.

Authors:  Andrew J Marek; Emily Y Chu; Michael E Ming; Zeeshan A Khan; Carrie L Kovarik
Journal:  Am J Clin Dermatol       Date:  2018-10       Impact factor: 7.403

6.  Randomized controlled trial of a sun protection intervention for children of melanoma survivors.

Authors:  Ellen R Gritz; Mary K Tripp; Susan K Peterson; Alexander V Prokhorov; Sanjay S Shete; Diana L Urbauer; Bryan M Fellman; Jeffrey E Lee; Jeffrey E Gershenwald
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10       Impact factor: 4.254

7.  Randomized trial of a web-based survivor intervention on melanoma prevention behaviors of first-degree relatives.

Authors:  Deborah J Bowen; Jennifer Hay; Hendrika Meischke; Joni A Mayer; Julie Harris-Wai; Wylie Burke
Journal:  Cancer Causes Control       Date:  2018-11-27       Impact factor: 2.506

Review 8.  Personalised risk communication for informed decision making about taking screening tests.

Authors:  Adrian G K Edwards; Gurudutt Naik; Harry Ahmed; Glyn J Elwyn; Timothy Pickles; Kerry Hood; Rebecca Playle
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

9.  Melanoma high-risk families' perceived health care provider risk communication.

Authors:  Lois J Loescher; Janice D Crist; Lee Cranmer; Clara Curiel-Lewandrowski; James A Warneke
Journal:  J Cancer Educ       Date:  2009       Impact factor: 2.037

10.  Differences in Sun Protection Behaviors Between Rural and Urban Communities in Texas.

Authors:  Sonia A Cunningham; Robert Yu; Sanjay Shete
Journal:  J Rural Health       Date:  2019-03-04       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.